cme.healio.com Open in urlscan Pro
107.154.114.198  Public Scan

Form analysis
0 forms found in the DOM

Text Content

 * MARK HOMONOFF Edit Profile
 * 0.00 TOTAL CREDITS
 * 0 IN PROGRESS
 * 0 SAVED

MENU

 * Home
 * News News
 * CME CME
 * Clinical Guidance Clinical Guidance
 * Account

All Specialties
 * All Specialties
 * Allergy/Asthma
 * Cardiology
 * Dermatology
 * Endocrinology
 * Gastroenterology
 * Hematology/Oncology
 * Infectious Disease
 * Nephrology
 * Neurology
 * Ophthalmology
 * Optometry
 * Pediatrics
 * Primary Care
 * Psychiatry
 * Pulmonology
 * Rheumatology
 * Women's Health & OB/GYN

My Account
Log Out
Log In
CME
Close Searchbar

 * News
 * CME
 * Clinical Guidance

 * Cart
 * Account
 * Log In Log In
 * Log Out Log Out

 * My Healio CME My Healio CME



 1. Healio
 2. CME
 3. Optometry

 * Overview
 * Poll
 * Pretest
 * Activity
   * In Case You Missed: Advancing Science in the Management of Demodex
     Blepharitis
   * Educational Tools
 * Posttest
 * Evaluation
 * Claim Credit
 * Certificate


IN CASE YOU MISSED: ADVANCING SCIENCE IN THE MANAGEMENT OF DEMODEX BLEPHARITIS

This activity is supported by an educational grant from Tarsus Pharmaceuticals,
Inc.

1.00 COPE
1.00 CPE
60 MINS
$0 FEE
SAVE
ADD TOPIC TO EMAIL ALERTS
Receive an email when new articles are posted on Optometry: Cornea/External
Disease
Subscribe
ADDED TO EMAIL ALERTS
You've successfully added Optometry: Cornea/External Disease to your alerts. You
will receive an email when new content is published.

Click Here to Manage Email Alerts
You've successfully added Optometry: Cornea/External Disease to your alerts. You
will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio
We were unable to process your request. Please try again later. If you continue
to have this issue please contact customerservice@slackinc.com.

Back to Healio
Start Activity



OVERVIEW


PROVIDER STATEMENT

This continuing education activity is provided by

Educational Partner

--------------------------------------------------------------------------------


SUPPORT STATEMENT

This activity is supported by an educational grant from Tarsus Pharmaceuticals,
Inc.

--------------------------------------------------------------------------------


ACTIVITY DESCRIPTION

Recent US studies have reported Demodex blepharitis infestation rates of 55% to
58% in eye care clinical patients. However, patients with Demodex blepharitis
may go undiagnosed or misdiagnosed due to overlapping symptoms seen in dry eye
disease and other ocular surface or lid margin disorders. Treatment can also be
challenging as there are currently no FDA-approved therapies and most
conventional options treat the symptoms of disease but not the underlying cause.
Emerging therapeutic options are currently under clinical investigation that
treat and target the underlying cause of Demodex blepharitis offering the
potential to resolve disease and improve patient quality of life measures. In
this continuing medical education activity, experts in the field review the
burden and prevalence of Demodex blepharitis, evaluate the efficacy of
conventional treatment strategies, and assess the latest clinical evidence
pertaining to emerging therapies that hold promise in the treatment of this
disease.

--------------------------------------------------------------------------------


TARGET AUDIENCE

The intended audience for this activity is ophthalmologists, optometrists,
pharmacists, and other health care professionals involved in treating Demodex
blepharitis.

--------------------------------------------------------------------------------


LEARNING OBJECTIVES

Upon successful completion of this activity, participants should be better able
to:

 * Review the burden and prevalence of Demodex blepharitis and the efficacy of
   conventional therapies used to treat the condition.
 * Assess new clinical evidence about emerging therapies that hold promise in
   the treatment of Demodex blepharitis.

--------------------------------------------------------------------------------


ACTIVITY CHAIR

Elizabeth Yeu, MD
Cornea, Cataract, External Disease and Refractive Surgery
Virginia Eye Consultants/EyeCare Partners
Medical Director, CVP Mid-Atlantic Surgery Center
Assistant Professor, Eastern Virginia Medical School
Norfolk, VA

--------------------------------------------------------------------------------


FACULTY

Marjan Farid, MD
Clinical Professor of Ophthalmology
Director of Cornea, Cataract and Refractive Surgery
Gavin Herbert Eye Institute
University of California, Irvine
Irvine, CA

Paul M. Karpecki, OD, FAAO
Director, Cornea Services
Kentucky Eye Institute
Lexington, KY

--------------------------------------------------------------------------------


PLANNERS/REVIEWERS

Ashay Bhatwadekar, PhD, RPh
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Jennifer Frederick, PharmD, BCPS

--------------------------------------------------------------------------------


ACCREDITATION

Purdue University is approved by the Council on Optometric Practitioner
Education (COPE) as an administrator/provider of continuing education (CE).

Vindico Medical Education is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for
physicians.

Vindico Medical Education is accredited by the Accreditation Council for
Pharmacy Education (ACPE) as a provider of continuing pharmacy education.

--------------------------------------------------------------------------------


CREDIT DESIGNATION

This enduring material is COPE-accredited for 1.0 continuing education credits
and is approved for one (1) year from the date of original release, December 30,
2022, to December 30, 2023.

COPE Course ID #: 82272-TD
COPE Activity ID #: 125223

Please consult your state’s Board of Optometry to determine if the CE credit may
apply toward your CE requirement for license renewal.

Vindico Medical Education designates this enduring material for a maximum of 1.0
AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit
commensurate with the extent of their participation in the activity.

This program is acceptable for 1.0 contact hour of ACPE Continuing Education
Credit. The ACPE Universal Program Number 0482-9999-22-036-H01-P, effective
12/30/2022. This is a knowledge-based activity, and there is no fee to attend.

Vindico Medical Education will provide pharmacist credits claimed information
directly to the ACPE through CPE Monitor within 30 days.

This enduring material is approved for 1 year from the date of original release,
December 30, 2022, to December 30, 2023.

--------------------------------------------------------------------------------


HOW TO PARTICIPATE IN THIS ACTIVITY AND OBTAIN CE CREDIT

To participate in this activity, you must read the objectives, answer the
polling and pretest questions, view the content, and complete the posttest and
evaluation. Provide only one (1) correct answer for each question. A
satisfactory score is defined as answering 70% of the posttest questions
correctly. If a satisfactory score on the posttest is achieved, Purdue
University will issue a CE Certificate or Vindico Medical Education will issue
an AMA PRA Category 1 Credit(s)™ Certificate or Statement of Continuing Pharmacy
Education Credit.

--------------------------------------------------------------------------------


DISCLOSURES

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and
Independence in Accredited Continuing Education. Any individuals in a position
to control the content of a continuing education activity, including faculty,
planners, reviewers, or others, are required to disclose all relevant financial
relationships with ineligible entities (commercial interests). All relevant
conflicts of interest have been mitigated prior to the commencement of the
activity.

Relationship information is accurate at the time of content development.

ACTIVITY CHAIR AND FACULTY REPORT THE FOLLOWING RELEVANT FINANCIAL
RELATIONSHIP(S)

Marjan Farid, MD
Advisor: Allergan, Bausch + Lomb, Bio-Tissue, Dompé, Johnson & Johnson Vision,
Kala, Novartis, Orasis, Sun, Tarsus, Zeiss
Consultant: Allergan, Bausch + Lomb, Bio-Tissue, Dompé, Johnson & Johnson
Vision, Kala, Novartis, Orasis, Sun, Tarsus, Zeiss

Paul M. Karpecki, OD, FAAO
Consultant: AdOM, Alcon, Aldeyra, Allergan/AbbVie, Atlas, Azura, Bausch + Lomb,
Bio-Tissue, Bruder, Cambium, Imprimis, Novartis, Oasis Medical, Oculus, OCuSOFT,
Olympic Ophthalmics, Oyster Point, RegenerEyes, Rendia, Santen, ScienceBased
Health, Scope, Sight Sciences, Silk Technologies, Sun, Surface, Tarsus, Thea,
Vital Tears
Individual Stocks and Stock Options: Tarsus

Elizabeth Yeu, MD
Consultant: AcuFocus, Advances Vision Group, Allergan, Aurion, Avellino, Bausch
+ Lomb/Valeant, Bio-Tissue, BlephEx, Bruder, BVI, CorneaGen, Dompé, Expert
Opinion, EyePoint, Glaukos, Guidepoint, Iveric Bio, Johnson & Johnson Vision,
Kala, Layer Bio, Lensar, Melt, Merck, New World Medical, Novartis, Ocular
Science, OCuSOFT, Omeros, Orasis, ScienceBased Health, Sight Sciences, STAAR,
Surface, Tarsus, Théa, Visus, Zeiss
Speaker Contracted by Ineligible Company: Alcon
Independent Research Contractor: AcuFocus, Alcon, Bio-Tissue, New World Medical,
Ocular Science, Tarsus
Individual Stocks and Stock Options: Advanced Vision Group, Aurion, Avellino,
BlephEx, Centricity, CorneaGen, Equinox, Expert Opinion, Layer Bio, Mati, Melt,
Modernizing Medicine, Ocular Science, Orasis, STAAR, Tarsus, Visus

PLANNERS/REVIEWERS REPORT THE FOLLOWING RELATIONSHIP(S)

Ashay Bhatwadekar, PhD, RPh
Consultant: Guidepoint, Ono Pharmaceutical
Independent Research Contractor: National Institute of Health
Ad hoc Pharmacist: CVS Health/Aetna

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Jennifer Frederick, PharmD, BCPS
No relevant financial relationships to disclose.

VINDICO MEDICAL EDUCATION STAFF REPORT THE FOLLOWING RELATIONSHIP(S)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical
Affairs and Compliance.

--------------------------------------------------------------------------------


UNLABELED AND INVESTIGATIONAL USAGE

The audience is advised that this continuing education activity may contain
references to unlabeled uses of US Food and Drug Administration (FDA)–approved
products or to products not approved by the FDA for use in the United States.
The faculty members have been made aware of their obligation to disclose such
usage.

--------------------------------------------------------------------------------


COPYRIGHT STATEMENT

Created and published by Vindico Medical Education, 6900 Grove Road, Building
100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680.
Printed in the USA. Copyright © 2022 Vindico Medical Education. All rights
reserved. No part of this publication may be reproduced without written
permission from the publisher.

The material presented at or in any Purdue University and Vindico Medical
Education continuing education activity does not necessarily reflect the views
and opinions of Purdue University or Vindico Medical Education. Neither Purdue
University, Vindico Medical Education, nor the faculty endorse or recommend any
techniques, commercial products, or manufacturers. The faculty/authors may
discuss the use of materials and/or products that have not yet been approved by
the FDA. All readers and continuing education participants should verify all
information before treating patients or utilizing any product.

--------------------------------------------------------------------------------


COPE QUESTIONS?

Contact us at pharmacy-cecr@purdue.edu

--------------------------------------------------------------------------------


CME/CPE QUESTIONS?

Contact us at CME@VindicoCME.com

Start Activity
 * Overview
 * Poll
 * Pretest
 * Activity
   * In Case You Missed: Advancing Science in the Management of Demodex
     Blepharitis
   * Educational Tools
 * Posttest
 * Evaluation
 * Claim Credit
 * Certificate





WE’RE SORRY, BUT AN UNEXPECTED ERROR HAS OCCURRED.

Please refresh your browser and try again. If this error persists, please
contact ITSupport@wyanokegroup.com for assistance.
Close

THE FEE FOR THIS ACTIVITY
IS $.



Go To Shopping Cart
Back To Activity


ARE YOU SURE YOU WANT TO LEAVE THIS ACTIVITY?

You haven't earned your CME credits yet.

Continue the Activity
Save Progress and Leave
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word word word word word word word word word
word word word word word word word word

mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1
mmMwWLliI0fiflO&1